Neurocrine jumps on analyst report

Neurocrine Biosciences Inc. (NASDAQ:NBIX) was up $1 (16%) to $7.34 on Friday after Jefferies analyst Thomas Wei initiated coverage on the stock with a "buy" and $12 price target. Wei said he was "conf...